Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Targeted therapies for malignant gliomas
Noman Ashraf, Edward Pan
Neurology & Neurotherapeutics - NE Neuro Oncology Sections
Simmons Comprehensive Cancer Center
Neurological Surgery
Neurology & Neurotherapeutics
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted therapies for malignant gliomas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Glioma
100%
Glioblastoma
80%
Ligands
38%
Temozolomide
33%
Angiogenesis Inducing Agents
30%
Bevacizumab
30%
United States Food and Drug Administration
26%
Standard of Care
26%
Brain Neoplasms
25%
Vascular Endothelial Growth Factor A
23%
Intercellular Signaling Peptides and Proteins
22%
Signal Transduction
21%
Carcinogenesis
20%
Stem Cells
19%
Monoclonal Antibodies
19%
Radiotherapy
18%
Therapeutics
17%
Drug Therapy
15%
Survival
15%
Chemical Compounds
Temozolomide
87%
Lethal
64%
Growth Factor
63%
Signal Transduction
58%
Marker
47%
Ligand
47%
Resistance
33%